17 September, 2017
Gratry & Company Llc sold 22,234 shares as Nippon Telegraph & Telephone A (NTT)'s stock 0.00%. On average, equities analysts predict that Horizon Pharma PLC will post $1.08 earnings per share for the current fiscal year. Kcg Holding Inc invested in 17,453 shares. The stock declined 0.91% or $0.45 reaching $49.11 per share. They now have a $17.00 price target on the biopharmaceutical company's stock. Deutsche Bank Ag sold 5,797 shares as Circor Intl Inc (CIR)'s stock rose 2.42%. About 7.90M shares traded or 92.68% up from the average.
Broadfin Capital Llc decreased Novadaq Technologies Inc (NASDAQ:NVDQ) stake by 4.77 million shares to 407,188 valued at $2.89M in 2016Q4. The lowest price the stock reached in the last trading day was $12.16 and compares with the $9.45 52-week low. The Deerfield Management Company holds 8.96 million shares with $144.92M value, up from 6.43 million last quarter. Stifel Nicolaus maintained Horizon Pharma PLC (NASDAQ:HZNP) rating on Tuesday, June 27.
Several equities analysts have commented on the stock. Therefore 17% are positive. Horizon Pharma PLC has an average rating of "Buy" and an average price target of $28.77. The Company's marketed medicines are ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), MIGERGOT (ergotamine tartrate & caffeine suppositories), PENNSAID (diclofenac sodium topical solution) 2% weight per weight (w/w), or PENNSAID 2%, PROCYSBI (cysteamine bitartrate) delayed-release capsules, QUINSAIR (aerosolized form of levofloxacin), RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium). The firm has "Hold" rating by TheStreet given on Friday, August 7. Cantor Fitzgerald maintained it with "Buy" rating and $17.0 target in Thursday, August 17 report. $94,800 worth of stock was bought by GREY MICHAEL G on Wednesday, May 10. The firm earned "Reduce" rating on Thursday, April 14 by SunTrust. The company was maintained on Thursday, July 13 by Cowen & Co. On Friday, December 9 the stock rating was downgraded by Mizuho to "Neutral".
Investors sentiment decreased to 0.92 in 2016 Q4. Its the same as in 2016Q3.
Several large investors have recently made changes to their positions in the stock. Swiss Bancorporation, Switzerland-based fund reported 103,850 shares. About 2.83M shares traded. (NYSE:CIR). Great West Life Assurance Com Can reported 20,609 shares stake.
Horizon Pharma PLC (NASDAQ:HZNP) last announced its earnings results on Monday, August 7th. 61,237 were reported by Tiaa Cref Invest Limited Liability. D E Shaw & Inc reported 0% in TechTarget Inc (NASDAQ:TTGT). Next Financial Group Inc holds 0% or 100 shares in its portfolio. Blackrock Lc has 0% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 262,037 shares. Millennium Lc owns 16,277 shares. Wells Fargo & Mn has 10,771 shares.
Investors sentiment decreased to 1.29 in 2016 Q4. Its up 0.14, from 1.04 in 2016Q3. 44 funds opened positions while 67 raised stakes. 1,543 were reported by Spot Trading Lc. Hsbc Hldgs Public Ltd Limited Liability Company reported 32,893 shares or 0% of all its holdings. Federated Investors Inc Pa reported 57,302 shares. Blackrock Inv Management Ltd holds 0.01% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP) for 603,431 shares. California State Teachers Retirement Sys has invested 0.01% in Horizon Pharma PLC (NASDAQ:HZNP). The current share price indicates that stock is -41.85% away from its one year high and is moving 201.11% ahead of its 52-week low. Clinton Gp, New York-based fund reported 37,557 shares. 150 are held by Markston Interest Limited. Airain reported 3,878 shares or 0.02% of all its holdings.
Piper Jaffray Companies set a $18.00 target price on Horizon Pharma PLC (NASDAQ:HZNP) in a research note published on Sunday morning. Comerica Bancorp accumulated 17,988 shares or 0.01% of the stock. Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 4,495 shares.
Since May 10, 2017, it had 1 buying transaction, and 0 selling transactions for $94,800 activity.
Among 6 analysts covering CIRCOR International (NYSE:CIR), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 77% are positive. Two analysts have issued estimates for Horizon Pharma PLC's earnings, with estimates ranging from $249.55 million to $258.72 million. Mizuho maintained Horizon Pharma PLC (NASDAQ:HZNP) rating on Monday, December 14. On Tuesday, November 8 the stock rating was maintained by Mizuho with "Buy". Stifel Nicolaus reissued a "buy" rating and issued a $20.00 price target (down from $35.00) on shares of Horizon Pharma PLC in a research note on Tuesday, May 9th. Mizuho maintained it with "Buy" rating and $25 target in Tuesday, May 3 report. On Wednesday, January 6 the stock rating was reinitiated by Citigroup with "Neutral". Rhumbline Advisers has invested 0.01% in Horizon Pharma PLC (NASDAQ:HZNP). They now have a Dollars 14 price target on the stock.
On 13 September 2017, Horizon Pharma Public Limited Company (NASDAQ:HZNP) stock price started the day at $13.36 and moved between $12.55 - 13.50 to finally close at $12.71. As per Tuesday, May 9, the company rating was downgraded by Mizuho. Finally, Mizuho reaffirmed a hold rating and set a $12.00 target price (up from $9.00) on shares of Horizon Pharma PLC in a research note on Monday, August 28th. Blackrock Grp holds 0% in Horizon Pharma PLC (NASDAQ:HZNP) or 106,963 shares. It also reduced its holding in Citigroup Inc (NYSE:C) by 12,100 shares in the quarter, leaving it with 16,501 shares, and cut its stake in Special Opportunities Fd Inc (SPE).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.